EGRIFTA WR™ (tesamorelin for injection) is approved in the U.S. for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy*. EGRIFTA WR™ is a growth hormone- releasing ...

MELBOURNE, Australia and INDIANAPOLIS, IN, USA I March 21, 2025 I Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces ...

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 ...

March 03, 2025--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot ...

The FDA approved the investigational new drug application for a phase 1 trial of ADCE-T02 in advanced solid tumors. The FDA cleared the investigational new drug (IND) application for a phase 1 trial ...

Compounding pharmacies have filed a lawsuit against the Food and Drug Administration following its removal of Novo Nordisk's semaglutide, a type of glucagon-like peptide-1, from a drug shortage list.

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a popular glucagon-like peptide 1 (GLP-1) weight loss and ...

See our full methodology. 1-800-PACK-RAT is a portable container company offering local, interstate, and long-distance transportation as well as storage options. One of the biggest benefits of ...